EUVIMEDOpdag EUVIMED
Video/Audio

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Satyabrata Bag, Santanu Ghosh, Roopa Lalwani, Pratishtha Vishnoi, Sudheer Gupta, Dhirendra Dubey

Journal of Visualized Experiments · 2023

DOI: 10.3791/66249 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2023. Written by Satyabrata Bag and 5 co-authors. Institution: 3B BlackBio Biotech India Limited; satya@3bblackbio.com. Major MEDLINE topics: Hepatitis B virus, Hepatitis B. Cited 1 times so far (Crossref); 24 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hepatitis B virus (HBV) is a significant cause of liver disease worldwide. It can lead to acute or chronic infections, making individuals highly susceptible to fatal cirrhosis and liver cancer. Accurate detection and quantification of HBV DNA in the blood are essential for diagnosing and monitoring HBV infection. The most common method for detecting HBV DNA is real-time PCR, which can be used to detect the virus and assess the viral load to monitor the response to antiviral therapy. Here, we describe a detailed protocol for the detection and quantification of HBV DNA in human serum or plasma using an IVD-marked real-time PCR-based kit. The kit uses primers and probes that target the highly conserved core region of the HBV genome and can accurately quantify all HBV genotypes (A, B, C, D, E, F, G, H, I, and J). The kit also includes an endogenous internal control to monitor possible PCR inhibition. This assay runs for 40 cycles, and its cutoff is 38 Ct. For the quantification of HBV DNA in clinical samples, a set of 5 quantification standards is provided with the kit. The standards contain known concentrations of HBV-specific DNA that are calibrated against the 4th WHO International Standard for HBV DNA for the nucleic acid test (NIBSC code 10/266). The standards are used to validate the functionality of the HBV-specific DNA amplification and to generate a standard curve, allowing the quantification of HBV DNA in a sample. HBV DNA as low as 2.5 IU/mL was detected using the PCR kit. The high sensitivity and reproducibility of the kit make it a powerful tool in clinical laboratories, aiding healthcare professionals in effectively diagnosing and managing HBV infections.

Subjects

MeSH terms (MEDLINE)

Hepatitis B virusHepatitis BHumansReal-Time Polymerase Chain ReactionDNA, ViralReproducibility of ResultsViral LoadSensitivity and Specificity

Substances

DNA, Viral

Authors and institutions

  • 3B BlackBio Biotech India Limited; satya@3bblackbio.com.
  • 3B BlackBio Biotech India Limited.
  • 3B BlackBio Biotech India Limited; d.dubey@3bblackbio.com.

Cite

APA

Bag, S., Ghosh, S., Lalwani, R., Vishnoi, P., Gupta, S., & Dubey, D. (2023). Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA. Journal of Visualized Experiments. https://doi.org/10.3791/66249

Vancouver

Bag S, Ghosh S, Lalwani R, Vishnoi P, Gupta S, Dubey D. Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA. Journal of Visualized Experiments. 2023. doi:10.3791/66249

BibTeX
@article{Bag2023,
  author = {Bag, Satyabrata and Ghosh, Santanu and Lalwani, Roopa and Vishnoi, Pratishtha and Gupta, Sudheer and Dubey, Dhirendra},
  title = {Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA},
  journal = {Journal of Visualized Experiments},
  year = {2023},
  doi = {10.3791/66249}
}
Start for free →